Your browser doesn't support javascript.
loading
Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.
Hanefeld, Markolf; Arteaga, Juan M; Leiter, Lawrence A; Marchesini, Giulio; Nikonova, Elena; Shestakova, Marina; Stager, William; Gómez-Huelgas, Ricardo.
Afiliação
  • Hanefeld M; Centre for Clinical Studies, GWT-Technical University Dresden, Dresden, Germany.
  • Arteaga JM; National University of Colombia School of Medicine, Bogotá D.C., Colombia.
  • Leiter LA; Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Toronto, Canada.
  • Marchesini G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Nikonova E; Artech Information Systems, LLC, Morristown, New Jersey.
  • Shestakova M; Endocrinology Research Center, Moscow, Russian Federation.
  • Stager W; I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
  • Gómez-Huelgas R; Sanofi, Bridgewater, New Jersey.
Diabetes Obes Metab ; 19(11): 1594-1601, 2017 11.
Article em En | MEDLINE | ID: mdl-28449324

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Diabetes Mellitus Tipo 2 / Insuficiência Renal Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Diabetes Mellitus Tipo 2 / Insuficiência Renal Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article